Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SP3NW is a Spokane, Washington-based life sciences startup incubator and regional innovation hub affiliated with Washington State University Health Sciences Spokane. Rather than operating as a drug developer itself, the organization provides wraparound incubation services, mentorship, funding connections, office and wet-lab ecosystem support, and commercialization assistance for early-stage companies in biotech, pharma, diagnostics, medical devices, and other health-related technologies. SP3NW launched in December 2020 to help translate university and regional innovation into scalable startups across the Inland Northwest. Its portfolio model and partnership network are designed to support company formation, business development, and technology commercialization rather than advancing an internal therapeutic pipeline. For a biotech analyst, SP3NW is best understood as an enabling ecosystem organization in life sciences, not a therapeutics company with proprietary clinical assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SP3NW.